All Publications
2024
Gonnelli A., Sarogni P., Giannini N., Linsalata S., Di Martino F., Zamborlin A., Frusca V., Ermini M.L., Puccini P., Voliani V., Paiar F.
A bioconvergence study on platinum-free concurrent chemoradiotherapyfor the treatment of HPV-negative head and neck carcinoma
Artificial cells, nanomedicine, and biotechnology, vol. 52, (no. 1), pp. 122-129
2024
Sarogni P., Frusca V., Zamborlin A., Giannini N., Menicagli M., Brancato L., Linsalata S., Di Martino F., Gonnelli A., Paiar F., Van den Bossche J., Bogers J., Voliani V.
Neoadjuvant Hyperthermia Combined with Hybrid Nanoarchitectures Enhances Chemoradiotherapy Efficacy in Head and Neck Carcinoma
ACS Applied Materials & Interfaces, vol. 16, pp. 43272-43282
Article
Journal
2024
Gonnelli A., Gerbé de Thoré M., Ermini M.L., Frusca V., Zamborlin A., Signolle N., Bawa O., Clémenson C., Meziani L., Bergeron P., El-Azrak I., Sarogni P., Mugnaioli E., Giannini N., Drava G., Deutsch E., Paiar F., Mondini M., Voliani V.
Nonpersistent Nanoarchitectures Enhance Concurrent Chemoradiotherapy in an Immunocompetent Orthotopic Model of HPV+ Head/Neck Carcinoma
Advanced Materials, vol. 36, (no. 28), pp. 2400949-2400949
2024
Sarogni P., Brindani N., Zamborlin A., Gonnelli A., Menicagli M., Mapanao A.K., Munafò F., De Vivo M., Voliani V.
Tumor growth-arrest effect of tetrahydroquinazoline-derivative human topoisomerase II-alpha inhibitor in HPV-negative head and neck squamous cell carcinoma
Scientific Reports
2023
Zamborlin A., Sarogni P., Frusca V., Gonnelli A., Giannini N., Ermini M.L., Marranci A., Paiari F., Mazzanti C.M., Seco J., Voliani V.
Drug-Free Hybrid Nanoarchitecture Modulation of the Metastatic Behavior of Pancreatic Ductal Adenocarcinoma in Alternative in Vivo Models
ACS Applied Nano Materials, vol. 6, (no. 24), pp. 22532-22544
Colleagues of Molecular Modeling and Drug Discovery